Cargando…
Individualized Treatment of Genotype 1 Naïve Patients: An Italian Multicenter Field Practice Experience
BACKGROUND: Triple therapy including Telaprevir or Boceprevir still represents in many European countries the standard of care for patients with Hepatitis C Virus genotype 1 infection. The number of patients who received this treatment resulted generally lower than expected. We investigated, among n...
Autores principales: | Mangia, Alessandra, Cenderello, Giovanni, Orlandini, Alessandra, Piazzolla, Valeria, Picciotto, Antonio, Zuin, Massimo, Ciancio, Alessia, Brancaccio, Giuseppina, Forte, Paolo, Carretta, Vito, Zignego, Anna Linda, Minerva, Nicola, Brindicci, Gaetano, Marignani, Massimo, Baroni, Gianluca Svegliati, Bertino, Gaetano, Cuccorese, Giuseppe, Mottola, Leonardo, Ripoli, Maria, Pirisi, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207756/ https://www.ncbi.nlm.nih.gov/pubmed/25340799 http://dx.doi.org/10.1371/journal.pone.0110284 |
Ejemplares similares
-
Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis?
por: Mangia, Alessandra, et al.
Publicado: (2020) -
SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study
por: Mangia, Alessandra, et al.
Publicado: (2019) -
Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013) -
Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020) -
Hematological Malignancies and HBV Reactivation Risk: Suggestions for Clinical Management
por: Zannella, Alessandra, et al.
Publicado: (2019)